Romano Brothers & Co’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.66M Hold
11,212
0.27% 93
2026
Q1
$2.37M Sell
11,212
-125
-1% -$26.9K 0.27% 97
2025
Q4
$2.33M Sell
11,337
-2,050
-15% -$386K 0.26% 99
2025
Q3
$2.1M Sell
13,387
-75
-0.6% -$11.6K 0.24% 104
2025
Q2
$2.26M Hold
13,462
0.28% 96
2025
Q1
$1.85M Sell
13,462
-50
-0.4% -$6.37K 0.24% 110
2024
Q4
$1.6M Hold
13,512
0.2% 125
2024
Q3
$1.49M Hold
13,512
0.19% 130
2024
Q2
$1.33M Sell
13,512
-450
-3% -$45.9K 0.18% 131
2024
Q1
$1.56M Sell
13,962
-300
-2% -$32.4K 0.21% 119
2023
Q4
$1.44M Sell
14,262
-350
-2% -$34.7K 0.21% 121
2023
Q3
$1.27M Hold
14,612
0.2% 129
2023
Q2
$1.38M Sell
14,612
-300
-2% -$25.3K 0.21% 124
2023
Q1
$1.13M Hold
14,912
0.17% 139
2022
Q4
$1.15M Sell
14,912
-575
-4% -$43.7K 0.17% 138
2022
Q3
$1.03M Buy
+15,487
New +$982K 0.17% 139

Other funds holding CAH

Romano Brothers & Co's CAH Position: Q2 2026 in Review

Romano Brothers & Co held its Cardinal Health (CAH) position steady in Q2 2026 at 11,212 shares worth $2.66M. The position accounts for 0.27% of the portfolio, ranked #93.

Romano Brothers & Co first reported a position in CAH in Q3 2022 and has held it in 16 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Romano Brothers & Co held 11,212 shares of Cardinal Health worth $2.66M as of Q2 2026.
  • Romano Brothers & Co left its Cardinal Health share count unchanged in Q2 2026.
  • Cardinal Health made up 0.27% of Romano Brothers & Co's portfolio in Q2 2026, its #93 holding.
  • Romano Brothers & Co first reported a position in Cardinal Health in Q3 2022 and has held it in 16 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Romano Brothers & Co's 13F filing for Q2 2026, filed 22 Jul 2026.